HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer.

Abstract
The WWP2 E3 ubiquitin ligase has previously been shown to regulate TGFβ/Smad signalling activity linked to epithelial-mesenchymal transition (EMT). Whilst inhibitory I-Smad7 was found to be the preferred substrate for full-length WWP2-FL and a WWP2-C isoform, WWP2-FL also formed a stable complex with an N-terminal WWP2 isoform (WWP2-N) in the absence of TGFβ, and rapidly stimulated activating Smad2/3 turnover. Here, using stable knockdown experiments we show that specific depletion of individual WWP2 isoforms impacts differentially on Smad protein levels, and in WWP2-N knockdown cells we unexpectedly find spontaneous expression of the EMT marker vimentin. Re-introduction of WWP2-N into WWP2-N knockout cells also repressed TGFβ-induced vimentin expression. In support of the unique role for WWP2-N in regulating TGFβ/Smad functional activity, we then show that a novel V717M-WWP2 mutant in the MZ7-mel melanoma cell line forms a stable complex with the WWP2-N isoform and promotes EMT by stabilizing Smad3 protein levels. Finally, we report the first analysis of WWP2 expression in cancer cDNA panel arrays using WWP2 isoform-specific probes and identify unique patterns of WWP2 isoform abundance associated with early/advanced disease stages. WWP2-N is significantly downregulated in stage IIIC melanoma and up-regulated in stage II/III prostate cancer, and we also find isolated examples of WWP2-FL and WWP2-C overexpression in early-stage breast cancer. Together, these data suggest that individual WWP2 isoforms, and particularly WWP2-N, could play central roles in tumourigenesis linked to aberrant TGFβ-dependent signalling function, and also have potential as both prognostic markers and molecular therapeutic targets.
AuthorsSurinder M Soond, Paul G Smith, Lloyd Wahl, Tracey E Swingler, Ian M Clark, Andrew M Hemmings, Andrew Chantry
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1832 Issue 12 Pg. 2127-35 (Dec 2013) ISSN: 0006-3002 [Print] Netherlands
PMID23938591 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013.
Chemical References
  • Biomarkers, Tumor
  • Protein Isoforms
  • RNA, Small Interfering
  • SMAD3 protein, human
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Luciferases
  • WWP2 protein, human
  • Ubiquitin-Protein Ligases
Topics
  • Apoptosis
  • Biomarkers, Tumor (metabolism)
  • Blotting, Western
  • Breast Neoplasms (metabolism, pathology)
  • Case-Control Studies
  • Cell Proliferation
  • Epithelial-Mesenchymal Transition
  • Female
  • Gene Expression Profiling
  • Humans
  • Immunoprecipitation
  • Luciferases (metabolism)
  • Male
  • Melanoma (metabolism, pathology)
  • Neoplasm Staging
  • Oligonucleotide Array Sequence Analysis
  • Prognosis
  • Prostatic Neoplasms (metabolism, pathology)
  • Protein Isoforms
  • RNA, Small Interfering (genetics)
  • Smad3 Protein (metabolism)
  • Transforming Growth Factor beta (metabolism)
  • Tumor Cells, Cultured
  • Ubiquitin-Protein Ligases (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: